These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35359855)

  • 1. Design and Characterization of Paclitaxel-Loaded Polymeric Nanoparticles Decorated With Trastuzumab for the Effective Treatment of Breast Cancer.
    Sakhi M; Khan A; Iqbal Z; Khan I; Raza A; Ullah A; Nasir F; Khan SA
    Front Pharmacol; 2022; 13():855294. PubMed ID: 35359855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer.
    Sun B; Ranganathan B; Feng SS
    Biomaterials; 2008 Feb; 29(4):475-86. PubMed ID: 17953985
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Gibbens-Bandala B; Morales-Avila E; Ferro-Flores G; Santos-Cuevas C; Meléndez-Alafort L; Trujillo-Nolasco M; Ocampo-García B
    Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110043. PubMed ID: 31546458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and In Vitro/Vivo Evaluation of Folate-conjugated Pluronic F87-PLGA/TPGS Mixed Nanoparticles for Targeted Drug Delivery.
    Wu T; Gong Y; Li Z; Li Y; Xiong X
    Curr Drug Deliv; 2021; 18(10):1505-1514. PubMed ID: 33845742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel-loaded PLGA nanoparticles: potentiation of anticancer activity by surface conjugation with wheat germ agglutinin.
    Mo Y; Lim LY
    J Control Release; 2005 Nov; 108(2-3):244-62. PubMed ID: 16213056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane®.
    Bernabeu E; Helguera G; Legaspi MJ; Gonzalez L; Hocht C; Taira C; Chiappetta DA
    Colloids Surf B Biointerfaces; 2014 Jan; 113():43-50. PubMed ID: 24060929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrospun micro- and nanofibers for sustained delivery of paclitaxel to treat C6 glioma in vitro.
    Xie J; Wang CH
    Pharm Res; 2006 Aug; 23(8):1817-26. PubMed ID: 16841195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential hepatic uptake of paclitaxel-loaded poly-(d-l-lactide-co-glycolide) nanoparticles - A possibility for hepatic drug targeting: Pharmacokinetics and biodistribution.
    Mandal D; Shaw TK; Dey G; Pal MM; Mukherjee B; Bandyopadhyay AK; Mandal M
    Int J Biol Macromol; 2018 Jun; 112():818-830. PubMed ID: 29421493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel.
    Muntimadugu E; Kumar R; Saladi S; Rafeeqi TA; Khan W
    Colloids Surf B Biointerfaces; 2016 Jul; 143():532-546. PubMed ID: 27045981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation.
    Madani F; Esnaashari SS; Bergonzi MC; Webster TJ; Younes HM; Khosravani M; Adabi M
    Life Sci; 2020 Sep; 256():117943. PubMed ID: 32531377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing and Formulation Optimization of Hyaluronic Acid Conjugated PLGA Nanoparticles of Tamoxifen for Tumor Targeting.
    Paswan SK; Saini TR; Jahan S; Ganesh N
    Pharm Nanotechnol; 2021; 9(3):217-235. PubMed ID: 33745427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of polymeric stabilizers on the size and stability of PLGA paclitaxel nanoparticles.
    Sakhi M; Khan A; Khan I; Ahmad Khan S; Irum Khan S; Ali Khattak M; Uddin MN; Kazi M; Nasir F
    Saudi Pharm J; 2023 Sep; 31(9):101697. PubMed ID: 37559864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of 6-Thioguanine conjugated PLGA nanoparticles through thioester bond formation: Benefits of electrospray mediated drug encapsulation and sustained release in cancer therapeutic applications.
    Chatterjee M; Jaiswal N; Hens A; Mahata N; Chanda N
    Mater Sci Eng C Mater Biol Appl; 2020 Sep; 114():111029. PubMed ID: 32994006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced intracellular delivery and controlled drug release of magnetic PLGA nanoparticles modified with transferrin.
    Cui YN; Xu QX; Davoodi P; Wang DP; Wang CH
    Acta Pharmacol Sin; 2017 Jun; 38(6):943-953. PubMed ID: 28552909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of biodegradable PLGA nanoparticles surface engineered with hyaluronic acid for targeted delivery of paclitaxel to triple negative breast cancer cells.
    Cerqueira BBS; Lasham A; Shelling AN; Al-Kassas R
    Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():593-600. PubMed ID: 28482569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifunctional HER2-antibody conjugated polymeric nanocarrier-based drug delivery system for multi-drug-resistant breast cancer therapy.
    Vivek R; Thangam R; NipunBabu V; Rejeeth C; Sivasubramanian S; Gunasekaran P; Muthuchelian K; Kannan S
    ACS Appl Mater Interfaces; 2014 May; 6(9):6469-80. PubMed ID: 24780315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity.
    Fonseca C; Simões S; Gaspar R
    J Control Release; 2002 Oct; 83(2):273-286. PubMed ID: 12363453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced apoptotic and anticancer potential of paclitaxel loaded biodegradable nanoparticles based on chitosan.
    Gupta U; Sharma S; Khan I; Gothwal A; Sharma AK; Singh Y; Chourasia MK; Kumar V
    Int J Biol Macromol; 2017 May; 98():810-819. PubMed ID: 28189791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced delivery of Paclitaxel using electrostatically-conjugated Herceptin-bearing PEI/PLGA nanoparticles against HER-positive breast cancer cells.
    Yu K; Zhao J; Zhang Z; Gao Y; Zhou Y; Teng L; Li Y
    Int J Pharm; 2016 Jan; 497(1-2):78-87. PubMed ID: 26617314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.